跳至主要内容
临床试验/NCT01176656
NCT01176656已完成不适用

Hypoglycemia: Physician and Patient Perspectives

AstraZeneca0 个研究点目标入组 800 人开始时间: 2010年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
800
主要终点
prevalence of hypoglycemia and impact of hypoglycemia

研究概览

简要总结

The purpose of this study is to assess the burden of hypoglycemia and identify unmet need related to the management of hypoglycemia among Type 2Diabetes Mellitus (T2DM) patients on OADs and/or insulin. This is an observational study which will identify patients with T2DM in an administrative claims database and will link claims data with results of patient and physician surveys concerning hypoglycemia.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • T2DM claims diagnosis (algorithm-based) with at least 2 pharmacy claims for an antidiabetic drug
  • at least 1 HbA1c test recorded during the identification period
  • continuous enrollment in the health plan for at least 12 months prior to survey date

排除标准

  • Type 1 Diabetes Mellitus
  • pregnancy or gestational diabetes

结局指标

主要结局

prevalence of hypoglycemia and impact of hypoglycemia

时间窗: October 2009-October 2010

次要结局

  • Patient Reported Outcomes of Hypoglycemia (including fear, awareness, behavioral modification and recovery from hypoglycemia)(October 2009-October 2010)
  • Treatment adherence and modification related to hypoglycemia, including health status, glycemic control and healthcare utilization(October 2009-October 2010)

研究者

发起方
AstraZeneca
申办方类型
Industry
责任方
Sponsor

相似试验